Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Goepfert

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 alleleGuido Ferrari, Wesley Neal, Janet Ottinger, et al.
Plos One|September 7, 2012
MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral loadHolly Janes, Nicole Frahm, Allan DeCamp, et al.
Vaccine|January 11, 2025
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®Sharon E Frey, Rebecca Brady, Lisa Jackson, et al.
Nature Medicine|July 25, 2006
Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometryPratip K Chattopadhyay, David A Price, Theresa F Harper, et al.
Plos One|September 21, 2011
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trialBeryl A Koblin, Martin Casapia, Cecilia Morgan, et al.
Vaccine|January 9, 2020
Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individualsSarah Sterrett, Binghao J Peng, Robert L Burton, et al.
Frontiers in Immunology|March 30, 2026
AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702Ferdinando Menezes, Shiyu Chen, Nicole Grunenberg, et al.
The Journal of Experimental Medicine|March 25, 2009
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipientsHayley Crawford, Wendy Lumm, Alasdair Leslie, et al.
Science Immunology|December 8, 2023
Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axisStephanie Jost, Olivier Lucar, Esther Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2026
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patientsAnoma Nellore, Paul Goepfert, Chen Sabrina Tan, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 alleleGuido Ferrari, Wesley Neal, Janet Ottinger, et al.
Plos One|September 7, 2012
MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral loadHolly Janes, Nicole Frahm, Allan DeCamp, et al.
Vaccine|January 11, 2025
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®Sharon E Frey, Rebecca Brady, Lisa Jackson, et al.
Nature Medicine|July 25, 2006
Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometryPratip K Chattopadhyay, David A Price, Theresa F Harper, et al.
Plos One|September 21, 2011
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trialBeryl A Koblin, Martin Casapia, Cecilia Morgan, et al.
Vaccine|January 9, 2020
Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individualsSarah Sterrett, Binghao J Peng, Robert L Burton, et al.
Frontiers in Immunology|March 30, 2026
AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702Ferdinando Menezes, Shiyu Chen, Nicole Grunenberg, et al.
The Journal of Experimental Medicine|March 25, 2009
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipientsHayley Crawford, Wendy Lumm, Alasdair Leslie, et al.
Science Immunology|December 8, 2023
Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axisStephanie Jost, Olivier Lucar, Esther Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2026
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patientsAnoma Nellore, Paul Goepfert, Chen Sabrina Tan, et al.
Pageof 6